Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge
Background - Patients have an increased risk of persistent/recurrent cervical disease if they received treatment for a high-grade squamous intraepithelial lesion (HSIL). Consequently, understanding whether co-testing (human papillomavirus [HPV] DNA testing and cervical cytology) is fully utilised by...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
The Royal Australian College of General Practitioners
2015
|
| Subjects: | |
| Online Access: | http://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf http://hdl.handle.net/20.500.11937/10779 |
| _version_ | 1848747626608984064 |
|---|---|
| author | Munro, A. Codde, J. Semmens, James Leung, Y. Spilsbury, Katrina Williams, Vincent Steel, N. Cohen, P. Pavicic, H. Westoby, V. O'Leary, Peter |
| author_facet | Munro, A. Codde, J. Semmens, James Leung, Y. Spilsbury, Katrina Williams, Vincent Steel, N. Cohen, P. Pavicic, H. Westoby, V. O'Leary, Peter |
| author_sort | Munro, A. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Background - Patients have an increased risk of persistent/recurrent cervical disease if they received treatment for a high-grade squamous intraepithelial lesion (HSIL). Consequently, understanding whether co-testing (human papillomavirus [HPV] DNA testing and cervical cytology) is fully utilised by general practitioners (GPs) is paramount. Methods - After consultation with key stakeholders, an anonymous, self-completion questionnaire was developed and disseminated to GPs who had provided cervical cytology. Results - Responses were received from 745 GPs (30.9% response rate). A significant number (34.3%) of GPs were unaware of the use of co-testing (HPV DNA testing and cervical cytology) for the management of patients after HSIL treatment. Additionally, the majority of GPs reported they did not ‘always’ receive a clear follow-up plan for patients after treatment of an HSIL. Discussion - GPs require further support and education to ensure successful adoption of co-testing (HPV DNA testing and cervical cytology), specifically, for patients treated for an HSIL. |
| first_indexed | 2025-11-14T06:52:08Z |
| format | Journal Article |
| id | curtin-20.500.11937-10779 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:52:08Z |
| publishDate | 2015 |
| publisher | The Royal Australian College of General Practitioners |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-107792017-01-30T11:20:57Z Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge Munro, A. Codde, J. Semmens, James Leung, Y. Spilsbury, Katrina Williams, Vincent Steel, N. Cohen, P. Pavicic, H. Westoby, V. O'Leary, Peter human papillomavirus [HPV] DNA cytology cervical disease high-grade squamous intraepithelial lesion (HSIL) Background - Patients have an increased risk of persistent/recurrent cervical disease if they received treatment for a high-grade squamous intraepithelial lesion (HSIL). Consequently, understanding whether co-testing (human papillomavirus [HPV] DNA testing and cervical cytology) is fully utilised by general practitioners (GPs) is paramount. Methods - After consultation with key stakeholders, an anonymous, self-completion questionnaire was developed and disseminated to GPs who had provided cervical cytology. Results - Responses were received from 745 GPs (30.9% response rate). A significant number (34.3%) of GPs were unaware of the use of co-testing (HPV DNA testing and cervical cytology) for the management of patients after HSIL treatment. Additionally, the majority of GPs reported they did not ‘always’ receive a clear follow-up plan for patients after treatment of an HSIL. Discussion - GPs require further support and education to ensure successful adoption of co-testing (HPV DNA testing and cervical cytology), specifically, for patients treated for an HSIL. 2015 Journal Article http://hdl.handle.net/20.500.11937/10779 http://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf The Royal Australian College of General Practitioners restricted |
| spellingShingle | human papillomavirus [HPV] DNA cytology cervical disease high-grade squamous intraepithelial lesion (HSIL) Munro, A. Codde, J. Semmens, James Leung, Y. Spilsbury, Katrina Williams, Vincent Steel, N. Cohen, P. Pavicic, H. Westoby, V. O'Leary, Peter Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title | Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title_full | Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title_fullStr | Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title_full_unstemmed | Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title_short | Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge |
| title_sort | utilisation of co-testing (human papillomavirus dna testing and cervical cytology) after treatment of cin: a survey of gps’ awareness and knowledge |
| topic | human papillomavirus [HPV] DNA cytology cervical disease high-grade squamous intraepithelial lesion (HSIL) |
| url | http://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf http://hdl.handle.net/20.500.11937/10779 |